The Claim
Oxidized eicosapentaenoic acid (EPA) inhibits cytokine-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human glomerular endothelial and mesangial cells, whereas native EPA does not inhibit this expression.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When eicosapentaenoic acid (EPA) is oxidized, it reduces the production of monocyte chemoattractant protein-1 (MCP-1) in specific kidney cells exposed to inflammatory signals, but unmodified EPA does not have this effect.
See the scientific wording
Oxidized eicosapentaenoic acid (EPA) inhibits cytokine-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human glomerular endothelial and mesangial cells, while native EPA does not, suggesting a selective effect on key chemokine pathways.
When EPA is oxidized, it enters kidney cells and stops a key inflammation signal from turning on. This signal normally tells the cells to make a chemical that pulls in white blood cells. Without this signal, the cells do not produce the chemical, so fewer white blood cells enter the kidney tissue.
What the research says
1 studyStudy: Oxidized ω–3 Fatty Acids Inhibit Pro-Inflammatory Responses in Glomerular Endothelial Cells
In lab-grown human kidney cells, when EPA gets oxidized (like when it’s been sitting out), it stops the cells from making a signal that pulls in white blood cells — but regular, unoxidized EPA doesn’t do anything. So oxidized EPA has a special anti-inflammatory effect.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.